ETF1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.638000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.490000E-02
Normal-vs-Stage2
3.613000E-01
Normal-vs-Stage3
8.499000E-01
Normal-vs-Stage4
2.970200E-02
Stage1-vs-Stage2
9.579800E-01
Stage1-vs-Stage3
1.246240E-01
Stage1-vs-Stage4
8.864000E-02
Stage2-vs-Stage3
2.078400E-01
Stage2-vs-Stage4
3.231600E-01
Stage3-vs-Stage4
5.434200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.457800E-01
Normal-vs-AfricanAmerican
4.542000E-01
Normal-vs-Asian
7.488600E-01
Caucasian-vs-AfricanAmerican
7.881600E-01
Caucasian-vs-Asian
3.658800E-01
AfricanAmerican-vs-Asian
5.605200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.146200E-01
Normal-vs-Female
2.914200E-01
Male-vs-Female
7.689800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.411440E-01
Normal-vs-Age(41-60Yrs)
1.000440E-01
Normal-vs-Age(61-80Yrs)
5.615600E-01
Normal-vs-Age(81-100Yrs)
5.349400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.544600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.120000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.382400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.422600E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.664400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.499600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.919800E-01
Normal-vs-Daily Drinker
7.224200E-01
Normal-vs-Weekly Drinker
5.509400E-01
Normal-vs-Occasional Drinker
1.876020E-01
Normal-vs-Social Drinker
1.459840E-01
Non Drinker-vs-Daily Drinker
6.802600E-01
Non Drinker-vs-Weekly Drinker
7.342800E-01
Non Drinker-vs-Occasional Drinker
1.748190E-01
Non Drinker-vs-Social Drinker
2.362800E-01
Daily Drinker-vs-Weekly Drinker
5.219800E-01
Daily Drinker-vs-Occasional Drinker
8.959700E-02
Daily Drinker-vs-Social Drinker
1.195620E-01
Weekly Drinker-vs-Occasional Drinker
4.573400E-01
Weekly Drinker-vs-Social Drinker
5.312400E-01
Occasional Drinker-vs-Social Drinker
8.765600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.219800E-01
Normal-vs-Grade 2
6.630600E-01
Normal-vs-Grade 3
6.579400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.804200E-02
Grade 1-vs-Grade 3
8.632300E-02
Grade 1-vs-Grade 4
5.219800E-01
Grade 2-vs-Grade 3
8.956800E-01
Grade 2-vs-Grade 4
6.630600E-01
Grade 3-vs-Grade 4
6.579400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.988000E-01
Normal-vs-NonDiabetic
4.004400E-01
Diabetic-vs-NonDiabetic
6.626200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.977970E-01
Normal-vs-NoPancreatitis
4.163800E-01
Pancreatitis-vs-NoPancreatitis
3.504000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.296600E-01
Normal-vs-N1
3.836400E-01
N0-vs-N1
9.581200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.810200E-01
Normal-vs-TP53-NonMutant
6.138200E-01
TP53-Mutant-vs-TP53-NonMutant
1.703800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
